From the publishers of The New England Journal of Medicine

Save time and stay informed. Our physician-editors offer you clinical perspectives on key research and news.

  1. Home>
  2. Specialties>
  3. General Medicine>
  4. Summary and Comment

New Renal Failure Patients Prefer Peritoneal Dialysis over Hemodialysis

It might be time to offer more information about dialysis options to new ESRD patients.

New end-stage renal disease (ESRD) patients must choose between hemodialysis (HD) and peritoneal dialysis (PD), but conflicting results about survival rates and outcomes have been reported for these options. In a U.S. prospective cohort study, which was conducted in 37 dialysis centers that offered both PD and HD, researchers assessed dialysis satisfaction among 736 new ESRD patients.

Satisfaction and health status were assessed with standardized questionnaires at a mean of 7 weeks after dialysis was begun. Compared with HD patients, PD patients were about 1.5 times to 2 times more likely to rate items pertaining to care and satisfaction as "excellent." Overall, 85% of PD patients and 56% of HD patients rated their care as excellent. Adjustment for a wide range of demographic factors did not alter the results.

Comment: An editorialist notes that PD use has declined to only 7.5% of new dialysis patients in the U.S. in 2001, despite equal or better outcomes and lower costs for home-based PD. This rate is lower than rates in other developed countries. The editorialist speculates that better physician training in PD, earlier patient referral, and earlier dialysis planning might increase use of PD. Meanwhile, the results of this study might help physicians offer better information about available choices to new ESRD patients.

— Thomas L. Schwenk, MD

Published in Journal Watch General Medicine March 5, 2004

Citation(s):

Rubin HR et al. Patient ratings of dialysis care with peritoneal dialysis vs hemodialysis. JAMA 2004 Feb 11; 291:697-703.

Heaf J. Underutilization of peritoneal dialysis. JAMA 2004 Feb 11; 291:740-2.

Your Remark:

Reader Remarks are intended to encourage lively discussion of clinical topics with your peers in the medical community. Please consider this when composing your remark.

Fields marked with an * are required.

Name as you'd like it to appear:

Submitting a comment indicates you have read and agreed to the remark guidelines and declare:*

PRIVACY: We will not use your email address, submitted for a comment, for any other purpose nor sell, rent, or share your e-mail address with any third parties. Please see our Privacy Policy.

 

CLEAR erases anything you've added in any part of the form. CONTINUE allows you to check your entire post (and edit it if necessary) before submitting.

To ensure that your Reader Remark is not formatted as one long paragraph, precede new paragraphs with either a blank line or an indentation.

Search

Advanced

Article Tools

Reader Remarks

Sign-In

Forgot your password?

New to Journal Watch?

E-mail Alerts

Delivered to your inbox.
Tailored to your interests. Free.

Sign Up Now!

Journal Watch Newsletters

Available in 13 specialties with convenient delivery and 10 free online CME exams.

Subscribe Now!

Copyright © 2004. Massachusetts Medical Society. All rights reserved.